1994
DOI: 10.1128/aac.38.4.702
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of transposon Tn1528, which confers amikacin resistance by synthesis of aminoglycoside 3'-O-phosphotransferase type VI

Abstract: Providencia stuartii BM2667, which was isolated from an abdominal abscess, was resistant to amikacin by synthesis of aminoglycoside 3'-O-phosphotransferase type VI. The corresponding gene, aph(3')-VIa, was carried by a 30-kb self-transferable plasmid of incompatibility group IncN. The resistance gene was cloned into pUC18, and the recombinant plasmid, pAT246, was transformed into Escherichia coli DH1 (recA) harboring pOX38Gm. The resulting clones were mixed with E. coli HB101 (recA), and transconjugants were u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
12
0

Year Published

1994
1994
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 32 publications
1
12
0
Order By: Relevance
“…APH(3=) is the most widespread phosphotransferase group among clinical pathogens, but the variant APH(3=)-VI was described in only a few Enterobacteriaceae and Acinetobacter species isolates (30)(31)(32). The APH(3=)-VI variants usually confer resistance to most aminoglycosides, including kanamycin, amikacin, neomycin, paromomycin, ribostamycin, butirosin, and isepamicin (33).…”
Section: Discussionmentioning
confidence: 99%
“…APH(3=) is the most widespread phosphotransferase group among clinical pathogens, but the variant APH(3=)-VI was described in only a few Enterobacteriaceae and Acinetobacter species isolates (30)(31)(32). The APH(3=)-VI variants usually confer resistance to most aminoglycosides, including kanamycin, amikacin, neomycin, paromomycin, ribostamycin, butirosin, and isepamicin (33).…”
Section: Discussionmentioning
confidence: 99%
“…A recent report (144) of plasmid-encoded amikacin resistance in clinical strains of P. aeruginosa may also reflect mobilization of an aac(6Ј) gene on, e.g., a transposon or integron. In one report, too, the aph(3Ј)-VIa gene of the highly amikacin-resistant strain being studied was present on a transposon (82). As with other aminoglycoside-modifying enzymes, genes for ANT enzymes can be integron associated, particularly the aadAencoded ANT(3Љ) (9) enzyme that inactivates streptomycin and spectinomycin and that is commonplace on class 1 integrons (72,73,109,143,151,162); but they can also be encoded by aadB, i.e., ANT(2Љ)-I (18) and, possibly, ANT(4Ј)-IIb (132).…”
Section: Modifying Enzymesmentioning
confidence: 99%
“…HpaA activation of these genes is stimulated by 4-HPA, suggesting that the phosphotransferase may, in fact, play an intended role in metabolism and only fortuitously provides resistance to aminoglycosides. APH(3Ј) enzymes that provide resistance to other aminoglycosides have also been described in P. aeruginosa and include APH(3Ј)-VI (amikacin and isepamicin) (74,82,99,156) and APH(2Љ) (gentamicin and tobramycin) (74). ANTs.…”
Section: Modifying Enzymesmentioning
confidence: 99%
“…As in other bacterial species, multidrug resistance can be achieved by two mechanisms: (i) horizontal transfer of genetic information and (ii) mutation of endogenous genes. Acquired resistance determinants that are carried by plasmids (18,28), transposons (23,29), and integrons (33,43) have been described for Acinetobacter spp. Determination of the genomic sequence of several A. baumannii strains has improved our knowledge of the ways in which A. baumannii can develop antibiotic resistance (1,21,38,45).…”
mentioning
confidence: 99%